Back to All Speakers

J. Taylor Hays, MD

Director of Nicotine Dependence Center, Mayo Clinic

Every person who seeks treatment for tobacco dependence deserves the best evidence-based treatment we can provide.

Learn why optimal use of pharmacotherapy is an important component of tobacco dependence treatment.

Dr. Hays has over 25 years of experience in treating tobacco dependence and researching new approaches to this treatment. This broad experience allows him to blend both the “art and science” of medicine and use it for the good of his patients.

The focus areas for his research include:

  • Study of the nicotine receptor partial agonist varenicline for tobacco dependence treatment
  • Study of the treatment of tobacco dependence among smokers with current or past alcohol abuse or dependence
  • Dissemination of evidence-based tobacco dependence treatment to health care providers within and outside the United States.

Tobacco use and dependence remain the number one cause of preventable and premature death in the United States. Dr. Hays focuses on effective treatments to help tobacco-dependent patients become smoke-free and reduce their risk of premature death.

Professional highlights

Associate Director, Nicotine Dependence Center, Mayo Clinic 

Chair, Personnel Committee, Mayo Clinic in Rochester, Minn.

Distinguished Clinician Award, Mayo Clinic, 2011

Diplomate, American Board of Addiction Medicine, 2010

Fellow, American College of Physicians, 2008

Board certification in Internal Medicine and Addiction Medicine

On the staff of Mayo Clinic since 1991

Internal Medicine Residency 1980-1984 Vanderbilt University

Professor of Medicine

MD – 1980 Vanderbilt University Medical School

Previous Sessions

Monday, May 22, 2017

Welcome Remarks, Course Introduction

Monday, May 22, 2017

Update on Pharmacotherapy

Tuesday, May 23, 2017

Welcome Remarks, Course Introduction

Monday, May 23, 2016

Welcome Remarks, Course Introduction

Monday, May 23, 2016

Panel: Global Context of Tobacco Dependence Treatment

The panel of international tobacco control experts discuss challenges faced by many countries in the implementation of tobacco dependence treatment, and the importance of tobacco dependence treatment as part of comprehensive tobacco control. The panel shares their perspectives on the interrelationships and synergy between tobacco dependence treatment and other components of comprehensive tobacco control.

Monday, May 23, 2016


Presenters provide a review of tobacco dependence pharmacotherapy with a focus on use in the hospital setting, use in people with serious mental illness, the role pharmacy professionals play in implementation of pharmacotherapy treatment, and the challenges of pharmacotherapy treatments in low resource settings.

Tuesday, May 24, 2016

Question and Answer Session

A town hall discussion facilitated by J. Taylor Hays, MD and Steven A. Schroeder, MD.

Tuesday, May 24, 2016

Town Hall: Overcoming Challenges and Barriers

A highly interactive session to identify, discuss and debate major learnings from the Summit. Audience input through response system and discussion are focused to identify strategic needs for promoting tobacco dependence treatment efforts in every WHO region.

Tuesday, May 24, 2016

Closing Remarks

J. Taylor Hays, MD provides summary points, review of highlights, and thanks.